Richard Elledge - Concepedia

Author

Richard Elledge

Also Known As

Elledge, Richard, R Elledge, R M Elledge, R. Elledge, R. M. Elledge, R.M. Elledge, Richard Elledge, Richard M Elledge, Richard M. Elledge

129

Publications

13.7K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine The University of Texas Health Science Center at San Antonio Methodist Hospital Houston Methodist The University of Texas at San Antonio

About

Richard Elledge is an author at Baylor College of Medicine specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	34	3K
2	Health Sciences	4	4	71
3	Engineering	2	2	922
4	Nursing	1	1	83
5	Public Health	1	1	83

Richard Elledge

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer Jenny C. Chang, Eric C. Wooten, Anna Tsimelzon, The Lancet Breast OncologyEngineeringMedicineTherapeutic ResponseCancer Genomics	2003	885
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Grazia Arpino, V J Bardou, Gary M. Clark, Breast Cancer Research	2004	855
Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer D. Craig Allred, Gary M. Clark, Richard Elledge, JNCI Journal of the National Cancer Institute	1993	781
Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases Valérie‐Jeanne Bardou, Grazia Arpino, Richard Elledge, Journal of Clinical Oncology	2003	748
Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial C. Kent Osborne, John Pippen, Stephen E. Jones, Journal of Clinical Oncology	2002	643
Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance Grazia Arpino, Heidi L. Weiss, Adrian V. Lee, JNCI Journal of the National Cancer Institute	2005	480
Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-Blind, Randomized Trial Anthony Howell, J.F.R. Robertson, P. Abram, Journal of Clinical Oncology	2004	424
Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States Richard Elledge, Gary M. Clark, Gary C. Chamness, JNCI Journal of the National Cancer Institute	1994	417
Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate Aman U. Buzdar, Joeri A J Douma, Nancy E. Davidson, Journal of Clinical Oncology	2001	363
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study Richard Elledge, Stephanie Green, R Pugh, International Journal of Cancer	2000	328

Page 1